ITRM930286A0 - Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego. - Google Patents

Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego.

Info

Publication number
ITRM930286A0
ITRM930286A0 IT93RM286A ITRM930286A ITRM930286A0 IT RM930286 A0 ITRM930286 A0 IT RM930286A0 IT 93RM286 A IT93RM286 A IT 93RM286A IT RM930286 A ITRM930286 A IT RM930286A IT RM930286 A0 ITRM930286 A0 IT RM930286A0
Authority
IT
Italy
Prior art keywords
headache
preparation
treatment
pharmaceutical composition
rectal administration
Prior art date
Application number
IT93RM286A
Other languages
English (en)
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of ITRM930286A0 publication Critical patent/ITRM930286A0/it
Publication of ITRM930286A1 publication Critical patent/ITRM930286A1/it
Application granted granted Critical
Publication of IT1261471B publication Critical patent/IT1261471B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ITRM930286A 1992-05-07 1993-05-06 Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego. IT1261471B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (3)

Publication Number Publication Date
ITRM930286A0 true ITRM930286A0 (it) 1993-05-06
ITRM930286A1 ITRM930286A1 (it) 1994-11-06
IT1261471B IT1261471B (it) 1996-05-23

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930286A IT1261471B (it) 1992-05-07 1993-05-06 Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego.

Country Status (33)

Country Link
US (1) US5705506A (it)
EP (1) EP0639072B1 (it)
JP (1) JPH07506570A (it)
KR (1) KR100253111B1 (it)
AT (1) ATE163850T1 (it)
AU (1) AU670083B2 (it)
BE (1) BE1007024A5 (it)
BG (1) BG62120B1 (it)
BR (1) BR1100108A (it)
CA (1) CA2135179C (it)
CH (1) CH685920A5 (it)
CY (1) CY2039B1 (it)
CZ (1) CZ283512B6 (it)
DE (1) DE69317418T2 (it)
ES (1) ES2113533T3 (it)
FR (1) FR2690847B1 (it)
GB (2) GB9209882D0 (it)
GR (1) GR3026584T3 (it)
HK (1) HK95697A (it)
HU (2) HU227338B1 (it)
IE (1) IE75203B1 (it)
IL (1) IL105468A (it)
IT (1) IT1261471B (it)
NO (1) NO306700B1 (it)
NZ (1) NZ252132A (it)
OA (1) OA10109A (it)
RO (1) RO112993B1 (it)
RU (1) RU2118527C1 (it)
SG (1) SG46649A1 (it)
TW (1) TW231970B (it)
UA (1) UA37206C2 (it)
WO (1) WO1993021916A1 (it)
ZA (1) ZA933178B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
TW570814B (en) * 1998-03-26 2004-01-11 Fujisawa Pharmaceutical Co Sustained-release pharmaceutical composition
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
CA3066426A1 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP2627328B1 (en) 2010-10-15 2016-09-14 Contera Pharma APS Combinations of serotonin receptor agonists for treatment of movement disorders
CA2870123C (en) 2012-04-18 2021-02-23 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
AU550010B2 (en) * 1980-08-12 1986-02-27 Glaxo Group Limited 5-tryptaminoacetamides, carbamates and ureas
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GR79215B (it) * 1982-06-07 1984-10-22 Glaxo Group Ltd
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
SE8505715L (sv) * 1984-12-04 1986-06-05 Glaxo Group Ltd Indolderivat
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
NO174052C (no) * 1987-08-13 1994-03-09 Glaxo Group Ltd Analogifremgangsmåte for fremstilling av terapeutisk aktive indolderivater
KR100215627B1 (ko) * 1990-06-07 1999-08-16 레슬리 제인 에드워즈 치료용 헤테로사이클 화합물

Also Published As

Publication number Publication date
CY2039B1 (en) 1998-04-30
FR2690847A1 (fr) 1993-11-12
HU227338B1 (en) 2011-04-28
ATE163850T1 (de) 1998-03-15
DE69317418D1 (de) 1998-04-16
JPH07506570A (ja) 1995-07-20
RU2118527C1 (ru) 1998-09-10
IL105468A (en) 1998-09-24
BG62120B1 (bg) 1999-03-31
HK95697A (en) 1997-08-08
ZA933178B (en) 1994-01-10
NO306700B1 (no) 1999-12-13
OA10109A (en) 1996-12-18
FR2690847B1 (fr) 1995-06-09
GB9209882D0 (en) 1992-06-24
IL105468A0 (en) 1993-08-18
SG46649A1 (en) 1998-02-20
CZ272394A3 (en) 1995-10-18
BE1007024A5 (fr) 1995-02-21
US5705506A (en) 1998-01-06
GR3026584T3 (en) 1998-07-31
ITRM930286A1 (it) 1994-11-06
DE69317418T2 (de) 1998-07-30
IT1261471B (it) 1996-05-23
UA37206C2 (uk) 2001-05-15
WO1993021916A1 (en) 1993-11-11
IE930339A1 (en) 1993-11-17
HUT71418A (en) 1995-11-28
BR1100108A (pt) 1999-12-07
CH685920A5 (fr) 1995-11-15
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
IE75203B1 (en) 1997-08-27
HU211638A9 (en) 1995-12-28
EP0639072A1 (en) 1995-02-22
TW231970B (it) 1994-10-11
GB9309209D0 (en) 1993-06-16
RO112993B1 (ro) 1998-03-30
NO944214L (no) 1994-11-07
BG99167A (bg) 1995-06-30
AU4064093A (en) 1993-11-29
AU670083B2 (en) 1996-07-04
CA2135179C (en) 2000-12-05
NZ252132A (en) 1996-09-25
NO944214D0 (no) 1994-11-04
CA2135179A1 (en) 1993-11-11
GB2266665B (en) 1996-05-22
KR100253111B1 (en) 2000-07-01
ES2113533T3 (es) 1998-05-01
CZ283512B6 (cs) 1998-04-15

Similar Documents

Publication Publication Date Title
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
ITRM910922A0 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e metodo per applicarla.
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
FI943421A0 (fi) 1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä
CA2083179A1 (en) Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
FI903845A7 (fi) Reniini-inhibiittoreita, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeissä
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
FI952230L (fi) Uusi aryylipropaanijohdannainen, menetelmä sen valmistamiseksi ja sen käyttö analgeettisena aineena
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
FI931336A7 (fi) Polyhydroksimetyleenijohdannaisia sisältäviä lääkkeitä, menetelmä niiden valmistamiseksi ja käyttämiseksi
FI945975A7 (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
FI963883L (fi) Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
ITRM930286A0 (it) Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego.
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
IT8219012A0 (it) Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
ITRM910963A0 (it) Composizione farmaceutica effervescente anticefalalgica e metodo per prepararla ed applicarla.
ITRM930183A0 (it) Metodo di terapia, in particolare di terapia estetica, sostanze in gelo crema per esaltare l'effetto del trattamento ed apparecchiatura relativa per l'applicazione del metodo.
IT8619457A0 (it) Derivati insaturi cicloalifatici, loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica.
ITMI921573A1 (it) Dispositivo di somministrazione di farmaci particolarmente per aerosolterapia e simili

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530